Volume 43, Issue 4, Pages 577-584 (October 2005) Is there a customised immunosuppressive regimen for patients transplanted with hepatocellular carcinoma?  Pietro Majno, Emiliano Giostra, Gilles Mentha, for the Geneva Liver Cancer Study Group  Journal of Hepatology  Volume 43, Issue 4, Pages 577-584 (October 2005) DOI: 10.1016/j.jhep.2005.07.018 Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Model of pulmonary metastasis from renal cell cancer in mice with (strain with severe combined immunodeficiency (SCID), to abolish the possible contribution of the immunosuppression induced by the drug). Lungs retrieved from untreated mice (c), and from cyclosporine-treated mice (d). Reproduced from Ref. [16], with permission. Journal of Hepatology 2005 43, 577-584DOI: (10.1016/j.jhep.2005.07.018) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Experimental implantation of syngenic colon tumour cells in mice. On the left tumour from a control animal, on the right the tumour from a mouse treated with Sirolimus at the equivalent therapeutic dose as in humans. Reproduced from Ref. [17], with permission. Journal of Hepatology 2005 43, 577-584DOI: (10.1016/j.jhep.2005.07.018) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions